Qnity
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Medical device or technology
Qnity is a deep-tech startup developing innovative platforms for molecular affinity assays based on the principles of quantum electrochemistry. Our technology enables highly precise and sensitive measurement of biomolecular interactions that are critical for drug development and diagnostics. By combining molecular interface engineering, advanced electrochemical sensors, and quantum signal analysis algorithms, Qnity offers a disruptive alternative to traditional methods such as SPR and ELISA.
Our mission is to accelerate drug discovery and deepen the understanding of complex diseases through solutions that make assays more accessible, scalable, and compatible with real samples. Qnity originated from research conducted at UNESP and Oxford, and has strategic partnerships with leading research centers, aiming for global impact in the pharmaceutical, biotech, and public health sectors.